BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11841407)

  • 1. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
    Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
    Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
    Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
    Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
    Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
    Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
    Hulkkonen J; Vilpo L; Hurme M; Vilpo J
    Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
    Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
    Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
    Ferrajoli A; Keating MJ; Manshouri T; Giles FJ; Dey A; Estrov Z; Koller CA; Kurzrock R; Thomas DA; Faderl S; Lerner S; O'Brien S; Albitar M
    Blood; 2002 Aug; 100(4):1215-9. PubMed ID: 12149200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
    Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
    Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.
    Thornton PD; Fernandez C; Giustolisi GM; Morilla R; Atkinson S; A'Hern RP; Matutes E; Catovsky D
    Hematol J; 2004; 5(2):145-51. PubMed ID: 15048065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
    Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
    Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
    Cuneo A; Rigolin GM; Bigoni R; De Angeli C; Veronese A; Cavazzini F; Bardi A; Roberti MG; Tammiso E; Agostini P; Ciccone M; Della Porta M; Tieghi A; Cavazzini L; Negrini M; Castoldi G
    Leukemia; 2004 Mar; 18(3):476-83. PubMed ID: 14712287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
    Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
    Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aberrations and CD38 expression in two siblings with B-cell chronic lymphocytic leukemia: a report of two siblings.
    Méhes L; Balázs M; Rejtö L; Telek B; Kiss A; Udvardy M
    Leuk Lymphoma; 2005 Mar; 46(3):421-3. PubMed ID: 15621833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.